Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, Barr H, Seger D, Ferraro DA, Pareja F, Gil-Henn H, Lapidot T, Alon R, Milanezi F, Symons M, Ben-Hamo R, Efroni S, Schmitt F, Wiemann S, Caldas C, Ehrlich M, Yarden Y.

Sci Signal. 2015 Jan 20;8(360):ra7. doi: 10.1126/scisignal.2005537.

PMID:
25605973
2.

Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.

Melchor L, Molyneux G, Mackay A, Magnay FA, Atienza M, Kendrick H, Nava-Rodrigues D, López-García MÁ, Milanezi F, Greenow K, Robertson D, Palacios J, Reis-Filho JS, Smalley MJ.

J Pathol. 2014 Jun;233(2):124-37. doi: 10.1002/path.4345.

PMID:
24615332
3.

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.

Wetterskog D, Lopez-Garcia MA, Lambros MB, A'Hern R, Geyer FC, Milanezi F, Cabral MC, Natrajan R, Gauthier A, Shiu KK, Orr N, Shousha S, Gatalica Z, Mackay A, Palacios J, Reis-Filho JS, Weigelt B.

J Pathol. 2012 Jan;226(1):84-96. doi: 10.1002/path.2974. Epub 2011 Oct 20.

PMID:
22015727
4.

Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.

Colombo PE, Milanezi F, Weigelt B, Reis-Filho JS.

Breast Cancer Res. 2011 Jun 27;13(3):212. doi: 10.1186/bcr2890. Review.

5.

Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?

Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F.

BMC Cancer. 2011 Jul 15;11:299. doi: 10.1186/1471-2407-11-299.

6.

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.

J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456. Epub 2011 Jun 16.

PMID:
21680574
7.

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.

Tan DS, Iravani M, McCluggage WG, Lambros MB, Milanezi F, Mackay A, Gourley C, Geyer FC, Vatcheva R, Millar J, Thomas K, Natrajan R, Savage K, Fenwick K, Williams A, Jameson C, El-Bahrawy M, Gore ME, Gabra H, Kaye SB, Ashworth A, Reis-Filho JS.

Clin Cancer Res. 2011 Mar 15;17(6):1521-34. doi: 10.1158/1078-0432.CCR-10-1688.

8.

Oncogenic mutations in gastric cancer with microsatellite instability.

Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R.

Eur J Cancer. 2011 Feb;47(3):443-51. doi: 10.1016/j.ejca.2010.09.008.

PMID:
20937558
9.

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F.

BMC Cancer. 2010 Sep 11;10:483. doi: 10.1186/1471-2407-10-483.

10.

Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.

Longatto-Filho A, Malheiro LF, Milanezi F, Pinheiro C, Baltazar F, Schmitt FC, Montironi R.

Anal Quant Cytol Histol. 2009 Oct;31(5):269-75.

PMID:
20701093
11.

P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.

Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F.

Histol Histopathol. 2010 Aug;25(8):963-74.

PMID:
20552547
12.

MSI phenotype and MMR alterations in familial and sporadic gastric cancer.

Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, Soares JM, Castedo S, Carneiro F, Roviello F, Oliveira C, Seruca R.

Int J Cancer. 2011 Apr 1;128(7):1606-13. doi: 10.1002/ijc.25495. Epub 2010 Jun 7.

13.

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation.

Albergaria A, Ribeiro AS, Pinho S, Milanezi F, Carneiro V, Sousa B, Sousa S, Oliveira C, Machado JC, Seruca R, Paredes J, Schmitt F.

Hum Mol Genet. 2010 Jul 1;19(13):2554-66. doi: 10.1093/hmg/ddq134. Epub 2010 Apr 12.

14.

PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer.

Carvalho S, Milanezi F, Costa JL, Amendoeira I, Schmitt F.

Virchows Arch. 2010 Mar;456(3):235-43. doi: 10.1007/s00428-010-0881-0. Epub 2010 Feb 4.

PMID:
20130907
15.

Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours.

Velho S, Oliveira C, Paredes J, Sousa S, Leite M, Matos P, Milanezi F, Ribeiro AS, Mendes N, Licastro D, Karhu A, Oliveira MJ, Ligtenberg M, Hamelin R, Carneiro F, Lindblom A, Peltomaki P, Castedo S, Schwartz S Jr, Jordan P, Aaltonen LA, Hofstra RM, Suriano G, Stupka E, Fialho AM, Seruca R.

Hum Mol Genet. 2010 Feb 15;19(4):697-706. doi: 10.1093/hmg/ddp536. Epub 2009 Dec 2.

16.

Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.

Lopes N, Sousa B, Vieira D, Milanezi F, Schmitt F.

Histopathology. 2009 Nov;55(5):594-9. doi: 10.1111/j.1365-2559.2009.03417.x.

PMID:
19912365
17.

Evaluation of HER2 in breast cancer: reality and expectations.

Milanezi F, Leitão D, Ricardo S, Augusto I, Schmitt F.

Expert Opin Med Diagn. 2009 Nov;3(6):607-20. doi: 10.1517/17530050903222221. Epub 2009 Sep 10.

PMID:
23496046
18.

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.

Martinho O, Longatto-Filho A, Lambros MB, Martins A, Pinheiro C, Silva A, Pardal F, Amorim J, Mackay A, Milanezi F, Tamber N, Fenwick K, Ashworth A, Reis-Filho JS, Lopes JM, Reis RM.

Br J Cancer. 2009 Sep 15;101(6):973-82. doi: 10.1038/sj.bjc.6605225. Epub 2009 Aug 25.

19.

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours.

Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F.

Breast Cancer Res. 2009;11(3):R40. doi: 10.1186/bcr2327. Epub 2009 Jun 23.

20.

Monoubiquitinylation regulates endosomal localization of Lst2, a negative regulator of EGF receptor signaling.

Mosesson Y, Chetrit D, Schley L, Berghoff J, Ziv T, Carvalho S, Milanezi F, Admon A, Schmitt F, Ehrlich M, Yarden Y.

Dev Cell. 2009 May;16(5):687-98. doi: 10.1016/j.devcel.2009.03.015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk